Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron for CINV in HEC and MEC (ESPNV)
NCT01481831Phase 4Completed
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Jul 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Shanghai Changzheng Hospital. Started Jul 2011; status: completed.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01481831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01481831.